Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet ​the main goal of a late-stage trial testing its ability to ‌reduce symptoms in adults during a simulated ...

Merck (MRK) stock returned 96% in the past twelve months, against 16.8% for the S&P 500. With the shares 4.0% below their ...

Moderna stock rallied by triple digits on Aug. 19 with positive news for its cancer vaccine. Is mRNA ready to return to the ...

NY Gov. Hochul declares a disaster emergency amid a measles outbreak, expands vaccine providers and testing access.

IBD’s coverage of the biotech stock news and pharma stocks today keeps you on top of these fast-moving companies. Today’s ...